Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Laufer

Showing results (181-190 of 189) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 189 results.
Journal of Medicinal Chemistry|October 20, 2021
Design of a "Two-in-One" Mutant-Selective Epidermal Growth Factor Receptor Inhibitor That Spans the Orthosteric and Allosteric SitesFlorian Wittlinger, David E Heppner, Ciric To, et al.
Journal of Medicinal Chemistry|January 15, 2025
Design, Synthesis, and Unprecedented Interactions of Covalent Dipeptide-Based Inhibitors of SARS-CoV-2 Main Protease and Its Variants Displaying Potent Antiviral ActivityPhilipp Flury, Nadine Krüger, Katharina Sylvester, et al.
Journal of Medicinal Chemistry|June 16, 2022
Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure-Activity Relationships, Antiviral Activity, and X-ray Structure DeterminationThanigaimalai Pillaiyar, Philipp Flury, Nadine Krüger, et al.
Immunity|March 9, 2022
A nonredundant role for T cell-derived interleukin 22 in antibacterial defense of colonic cryptsCarlene L Zindl, Steven J Witte, Vincent A Laufer, et al.
Journal of Medicinal Chemistry|September 11, 2025
Azapeptide-Based SARS-CoV-2 Main Protease Inhibitors: Design, Synthesis, Enzyme Inhibition, Structural Determination, and Antiviral ActivityPhilipp Flury, Jyoti Vishwakarma, Katharina Sylvester, et al.
Communications Chemistry|February 20, 2024
Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitorsFlorian Wittlinger, Blessing C Ogboo, Ekaterina Shevchenko, et al.
Archiv Der Pharmazie|January 10, 2026
New Quinoline Kinase Inhibitors With Good Selectivity for NAK Kinases and Anti-Tumor Activity Against Ewing SarcomaCaroline de Bem Gentz, Thais Helena Maciel Fernandes, Marcela Silva Lopes, et al.
Journal of Medicinal Chemistry|December 3, 2024
Tilting the Scales toward EGFR Mutant Selectivity: Expanding the Scope of Bivalent "Type V" Kinase InhibitorsFlorian Wittlinger, Surbhi P Chitnis, Calvin D Pham, et al.
Nature Genetics|November 5, 2022
Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritisKazuyoshi Ishigaki, Saori Sakaue, Chikashi Terao, et al.
Pageof 19

Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Journal of Medicinal Chemistry|October 20, 2021
Design of a "Two-in-One" Mutant-Selective Epidermal Growth Factor Receptor Inhibitor That Spans the Orthosteric and Allosteric SitesFlorian Wittlinger, David E Heppner, Ciric To, et al.
Journal of Medicinal Chemistry|January 15, 2025
Design, Synthesis, and Unprecedented Interactions of Covalent Dipeptide-Based Inhibitors of SARS-CoV-2 Main Protease and Its Variants Displaying Potent Antiviral ActivityPhilipp Flury, Nadine Krüger, Katharina Sylvester, et al.
Journal of Medicinal Chemistry|June 16, 2022
Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure-Activity Relationships, Antiviral Activity, and X-ray Structure DeterminationThanigaimalai Pillaiyar, Philipp Flury, Nadine Krüger, et al.
Immunity|March 9, 2022
A nonredundant role for T cell-derived interleukin 22 in antibacterial defense of colonic cryptsCarlene L Zindl, Steven J Witte, Vincent A Laufer, et al.
Journal of Medicinal Chemistry|September 11, 2025
Azapeptide-Based SARS-CoV-2 Main Protease Inhibitors: Design, Synthesis, Enzyme Inhibition, Structural Determination, and Antiviral ActivityPhilipp Flury, Jyoti Vishwakarma, Katharina Sylvester, et al.
Communications Chemistry|February 20, 2024
Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitorsFlorian Wittlinger, Blessing C Ogboo, Ekaterina Shevchenko, et al.
Archiv Der Pharmazie|January 10, 2026
New Quinoline Kinase Inhibitors With Good Selectivity for NAK Kinases and Anti-Tumor Activity Against Ewing SarcomaCaroline de Bem Gentz, Thais Helena Maciel Fernandes, Marcela Silva Lopes, et al.
Journal of Medicinal Chemistry|December 3, 2024
Tilting the Scales toward EGFR Mutant Selectivity: Expanding the Scope of Bivalent "Type V" Kinase InhibitorsFlorian Wittlinger, Surbhi P Chitnis, Calvin D Pham, et al.
Nature Genetics|November 5, 2022
Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritisKazuyoshi Ishigaki, Saori Sakaue, Chikashi Terao, et al.
Pageof 19